Skip to main content

Published locations for New B-Cell Depleting Agent Is Well Tolerated : TRU-015 resulted in ACR20 improvement in half of 36 patients studied; 25% had ACR50 responses.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. New B-Cell Depleting Agent Is Well Tolerated : TRU-015 resulted in ACR20 improvement in half of 36 patients studied; 25% had ACR50 responses.

User login

  • Reset your password
  • /content/new-b-cell-depleting-agent-well-tolerated-tru-015-resulted-acr20-improvement-half-36
  • /rheumatologynews/article/44836/rheumatoid-arthritis/new-b-cell-depleting-agent-well-tolerated-tru
  • /rheumatology/article/44836/rheumatoid-arthritis/new-b-cell-depleting-agent-well-tolerated-tru-015